Small Molecules
30 October 2013
Spectrum Pharmaceuticals Announces Completion of Enrollment, in Pivotal Trial of Captisol-Enabled(R) (Propylene Glycol-Free) Melphalan29 October 2013
Sunovion Presents Data at CHEST 2013 from a One-year, Large Simple Safety Study of BROVANA® (arformoterol tartrate) Inhalation Solution29 October 2013
Lumena Pharmaceuticals Initiates the CLARITY Phase II Study of LUM001 in Patients with Primary Biliary Cirrhosis29 October 2013
Addex Licensee Completes Enrolment of 120 Patients in a Phase 2 Clinical Trial of ADX71149 for the Treatment of Anxious Depression29 October 2013
ARCA biopharma Announces IND Submission to US FDA for Gencaro for the Treatment of Atrial Fibrillation29 October 2013
New data show Striverdi® (olodaterol)* Respimat® improves exercise tolerance in patients with moderate to very severe COPD129 October 2013
A Phase 1 ready novel sodium channel blocker CNV1061436 for CNS disorders is added to the pipeline of clinical development candidate28 October 2013
Kinex Announces First Patient Dosed in Phase Ib Study of Oraxol, an Orally Dosed Paclitaxel28 October 2013
Oral Apremilast Demonstrated Clinically Meaningful and Statistically Significant Improvements in Enthesitis and Dactylitis28 October 2013
Oral Apremilast Demonstrated Long-Term Clinical Benefits for Patients with Psoriatic Arthritis28 October 2013
Loxo Oncology Announces Lead Program, a Highly Potent, Selective Trk Kinase Inhibitor28 October 2013
Pulmatrix Announces Positive Results from Initial Stage of Phase IB Clinical Study of PUR0200 in COPD Patients28 October 2013
Clovis Oncology’s CO-1686 Continues to Demonstrate Promising Clinical Activity and Safety in Updated Phase I Study Results26 October 2013
Lundbeck receives positive opinion for approval of Brintellix (vortioxetine) in the European Union26 October 2013
FDA Grants Breakthrough Therapy Designation to cPMP Replacement Therapy for Patients with Molybdenum Cofactor Deficiency (MoCD) Type A26 October 2013
Zogenix Receives FDA Approval for Zohydro(TM) ER (hydrocodone bitartrate) Extended-Release Capsules26 October 2013
GE Healthcare Announces FDA Approval of Vizamyl™ (Flutemetamol F18 Injection) for Detection of Beta Amyloid26 October 2013
FDA Advisory Committee Supports Approval of Gilead’s Sofosbuvir for Chronic Hepatitis C Infection26 October 2013
Actelion receives positive CHMP opinion for Opsumit (macitentan) for the long-term treatment of pulmonary arterial hypertension26 October 2013
FDA Approves Addition to CIALIS® (tadalafil) Product LabelNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports